##gff-version 3
##sequence-region Q9UQ52 1 1028
Q9UQ52	UniProtKB	Signal peptide	1	19	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Chain	20	999	.	.	.	ID=PRO_0000014727;Note=Contactin-6	
Q9UQ52	UniProtKB	Propeptide	1000	1028	.	.	.	ID=PRO_0000014728;Note=Removed in mature form;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Domain	26	117	.	.	.	Note=Ig-like C2-type 1	
Q9UQ52	UniProtKB	Domain	122	208	.	.	.	Note=Ig-like C2-type 2	
Q9UQ52	UniProtKB	Domain	227	308	.	.	.	Note=Ig-like C2-type 3	
Q9UQ52	UniProtKB	Domain	318	402	.	.	.	Note=Ig-like C2-type 4	
Q9UQ52	UniProtKB	Domain	408	495	.	.	.	Note=Ig-like C2-type 5	
Q9UQ52	UniProtKB	Domain	499	587	.	.	.	Note=Ig-like C2-type 6	
Q9UQ52	UniProtKB	Domain	600	698	.	.	.	Note=Fibronectin type-III 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
Q9UQ52	UniProtKB	Domain	703	800	.	.	.	Note=Fibronectin type-III 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
Q9UQ52	UniProtKB	Domain	805	901	.	.	.	Note=Fibronectin type-III 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
Q9UQ52	UniProtKB	Domain	902	996	.	.	.	Note=Fibronectin type-III 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00316	
Q9UQ52	UniProtKB	Modified residue	882	882	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q9UQ52	UniProtKB	Lipidation	999	999	.	.	.	Note=GPI-anchor amidated serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	65	65	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	193	193	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	368	368	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	377	377	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	468	468	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	659	659	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	765	765	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	860	860	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	865	865	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	895	895	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	931	931	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	956	956	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Glycosylation	957	957	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9UQ52	UniProtKB	Disulfide bond	50	100	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
Q9UQ52	UniProtKB	Disulfide bond	144	196	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
Q9UQ52	UniProtKB	Disulfide bond	249	297	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
Q9UQ52	UniProtKB	Disulfide bond	339	386	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
Q9UQ52	UniProtKB	Disulfide bond	431	479	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
Q9UQ52	UniProtKB	Disulfide bond	521	577	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00114	
Q9UQ52	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_035509;Note=In a breast cancer sample%3B somatic mutation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q9UQ52	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_033611;Note=F->S;Dbxref=dbSNP:rs6808056	
Q9UQ52	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_065744;Note=R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21220648;Dbxref=dbSNP:rs41293401,PMID:21220648	
Q9UQ52	UniProtKB	Natural variant	314	314	.	.	.	ID=VAR_065745;Note=F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21220648;Dbxref=dbSNP:rs774763830,PMID:21220648	
Q9UQ52	UniProtKB	Natural variant	440	440	.	.	.	ID=VAR_019913;Note=A->S;Dbxref=dbSNP:rs265771	
Q9UQ52	UniProtKB	Natural variant	585	585	.	.	.	ID=VAR_035510;Note=In a breast cancer sample%3B somatic mutation. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q9UQ52	UniProtKB	Natural variant	954	954	.	.	.	ID=VAR_065746;Note=In a patient with amyotrophic lateral sclerosis. E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21220648;Dbxref=dbSNP:rs1447631177,PMID:21220648	
